Nu Skin Enterprises, Inc.

NUS Consumer Defensive Household & Personal Products

Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.87 0.13 +2.74%
Market cap
$237.1M
P/E
0.0×
Fwd P/E
5.9×
Dividend yield
4.93%
F-score
7/9
Altman Z
3.78
Beneish M
−2.35
Dividend safety
70/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
239.84 197.99 267.82 278.51 354.81 423.90 344.04 398.26 438.25 368.13
Receivables
39.54 50.78 58.70 47.36 41.30 63.37 50.38 53.28 33.20 31.20
Inventory
178.64 190.24 279.98 346.18 399.93 314.37 275.89 295.82 253.45 249.94
Other current assets
— 26.94 14.32 76.00 63.00 91.00 62.00 45.00 49.00 54.00
Total current assets
547.70 538.60 701.87 759.87 872.95 903.20 740.17 799.24 777.79 714.34
Property, Plant, Equpment (Net)
377.17 379.60 432.97 444.81 453.67 468.18 453.60 464.54 464.59 444.73
Goodwill and Intangible Assets (Total)
126.24 157.90 313.43 273.13 283.42 292.51 276.89 286.56 182.60 178.51
Long-term assets (Other)
280.19 320.21 270.26 244.43 175.46 138.08 154.02 144.11 164.90 136.47
Total non-current assets
857.62 930.31 1,106.76 1,061.10 1,033.53 1,053.88 1,028.84 895.21 812.08 759.71
Total Assets
1,405.31 1,468.91 1,808.63 1,820.97 1,906.48 1,957.08 1,769.01 1,694.45 1,589.87 1,474.05
Accounts Payable
26.18 34.88 43.11 53.96 49.99 66.17 38.98 47.62 50.34 41.26
Accrued Expenses
217.55 217.81 253.70 280.28 372.20 446.68 290.28 322.58 319.19 275.02
Current Part of Debt
20.00 30.00 25.00 25.00 107.50 30.00 27.50 69.46 77.84 82.73
Other current liabilities
— 13.92 7.06 251.00 339.00 388.00 251.00 316.00 306.00 275.00
Total current liabilities
263.73 296.61 328.87 359.24 529.69 542.86 356.76 439.66 447.37 399.01
Long Term Debt (Total)
204.19 363.61 478.04 377.47 268.78 305.39 334.46 361.01 310.79 334.17
Non-current Liabilities (Other)
74.51 98.80 108.80 110.43 106.47 102.28 96.80 111.92 127.12 76.80
Total non-current liabilities
336.34 520.85 657.79 564.43 464.01 519.95 536.96 472.92 437.91 410.96
Total liabilities
600.07 817.46 986.66 923.67 993.71 1,062.81 893.72 912.58 885.28 809.98
Additional Paid In Capital
635.99 627.79 621.85 613.28 601.70 579.80 557.54 552.56 466.35 439.64
Common Stock (Net)
0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09
Retained Earnings
1,860.32 1,711.95 1,870.47 1,939.50 1,911.73 1,840.74 1,727.77 1,635.75 1,609.17 1,558.59
Treasury Stock
1,575.06 1,563.61 1,570.44 1,569.06 1,526.86 1,461.59 1,324.83 1,326.61 1,304.69 1,250.12
Common Equity (Total)
805.24 651.45 821.97 897.30 912.77 894.27 875.29 781.87 704.60 664.07
Shareholders Equity (Total)
805.24 651.46 821.97 897.30 912.77 894.27 875.29 781.87 704.60 664.07
Shareholders Equity and Liabilities (Total)
1,405.31 1,468.91 1,808.63 1,820.97 1,906.48 1,957.08 1,769.01 1,694.45 1,589.87 1,474.05
Shares (Common)
48.20 49.80 49.50 49.50 49.90 50.90 55.60 55.40 52.70 52.70
Shareholders Equity (Tangible)
679.00 493.55 508.54 624.16 629.35 601.76 598.40 495.31 521.99 485.56
Net Debt
(15.65) 195.62 235.22 123.96 21.47 (88.51) 17.92 32.21 (49.62) 48.77
Total Debt
224.19 393.61 503.04 402.47 376.28 335.39 361.96 430.46 388.63 416.89

Fold the line items

In millions of $ except per-share values · columns are period end dates